BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7693928)

  • 1. Dyshormonogenetic goitre.
    Vittal S; Chandrasekaran M; Kumar KB; Sucharitha V; Jeevaratinam R
    J R Coll Surg Edinb; 1993 Aug; 38(4):205-7. PubMed ID: 7693928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for thyroxine therapy after surgery for nontoxic benign goitre.
    Berglund J; Bondesson L; Christensen SB; Larsson AS; Tibblin S
    Acta Chir Scand; 1990; 156(6-7):433-8. PubMed ID: 2368548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy.
    Erbil Y; Ozbey N; Giriş M; Salmaslioğlu A; Ozarmağan S; Tezelman S
    Br J Surg; 2007 Dec; 94(12):1485-90. PubMed ID: 17703499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High long term recurrence rate after subtotal thyroidectomy for nodular goitre.
    Röjdmark J; Järhult J
    Eur J Surg; 1995 Oct; 161(10):725-7. PubMed ID: 8555339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multinodular goiter in children].
    Léger J; Nihoul-Fékété C; Iris L; Czernichow P
    Arch Fr Pediatr; 1987 Oct; 44(8):579-82. PubMed ID: 3442459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of cancer in endemic multinodular goitre.
    Nmadu PT; Mabogunje OA
    Cent Afr J Med; 1991 Aug; 37(8):242-4. PubMed ID: 1807796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of patients with euthyroid goiter].
    Hermus AR; Huysmans DA
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1623-7. PubMed ID: 10972051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effect of 131I therapy of multinodular non-toxic goiter].
    Nygaard B; Hegedüs L; Gervil M; Jensen HH; Søe-Jensen P; Hansen JE
    Ugeskr Laeger; 1994 Sep; 156(39):5699-703. PubMed ID: 7985257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
    Fast S; Bonnema SJ; Hegedüs L
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid auto-antibodies, lymphocytic infiltration and the development of post-operative hypothyroidism following hemithyroidectomy for non-toxic nodular goitre.
    Buchanan MA; Lee D
    J R Coll Surg Edinb; 2001 Apr; 46(2):86-90. PubMed ID: 11329748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene.
    Banghova K; Cinek O; Al Taji E; Zapletalova J; Vidura R; Lebl J
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1179-84. PubMed ID: 19189692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical indications and techniques in Basedow's disease, multinodular goiter and thyroid cancers].
    Tschantz P; Sohrabi N; Dojcinovic S; Chèvre F
    Rev Med Suisse Romande; 2001 May; 121(5):337-9. PubMed ID: 11450188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benign thyroid disease: 20-year experience in surgical therapy].
    Zaraca F; Di Paola M; Gossetti F; Proposito D; Filippoussis P; Montemurro L; Mancini B; Gallina S; Talarico E; Talarico C; Lazzaro M; Mulieri G; Flati D; Flati G; Carboni M
    Chir Ital; 2000; 52(1):41-7. PubMed ID: 10832525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The choice of the intervention in the surgical treatment of nontoxic diffuse multinodular goiter].
    Uccheddu A; Cois A; Licheri S
    Minerva Chir; 1996; 51(1-2):25-32. PubMed ID: 8677042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and prevention of recurrent goiter.
    Kraimps JL; Marechaud R; Gineste D; Fieuzal S; Metaye T; Carretier M; Barbier J
    Surg Gynecol Obstet; 1993 Apr; 176(4):319-22. PubMed ID: 8460405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy of euthyroid multinodular goitres.
    Manders JM; Corstens FH
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S466-70. PubMed ID: 12192547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of infective thyroiditis in nodular goitres.
    Ameh EA; Sabo SY; Nmadu PT
    East Afr Med J; 1998 Jul; 75(7):425-7. PubMed ID: 9803636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid malignancy in multinodular goitre and solitary nodule.
    Abu-Eshy SA; Khan AR; Khan GM; al-Humaidi MA; al-Shehri MY; Malatani TS
    J R Coll Surg Edinb; 1995 Oct; 40(5):310-2. PubMed ID: 8523308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.